CoChat

Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

The present 16-week double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of lamotrigine add-on pharmacotherapy on clinical symptomatology and cognitive functioning in a sample of patients with treatment-resistant obsessive–compulsive disorder (OCD) receiving serotonin reuptake inhibitors (SRIs). After clinical and neurocognitive assessments, patients were randomly allocated to receive, in a double-blind design, 100 mg/day of lamotrigine or a placebo. A final sample of 33 patients completed the study. The results obtained indicate that lamotrigine added to stable SRI treatment substantially improved obsessive–compulsive (Yale–Brown Obsessive Compulsive Scale: obsessions, p < 0.0001; compulsions, p < 0.0001; total score, p < 0.0001), and affective symptoms (Hamilton Rating Scale for Depression p < 0.0001). Regarding cognitive functions, improvement was observed only in Semantic Fluency ( p = 0.004). The findings provide evidence that lamotrigine augmentation of SRI treatment is well tolerated and may be proposed as an effective therapeutic strategy to improve outcome in treatment-resistant OCD.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881111431751

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 7

  1. Deltito JA, 1994, J Clin Psychiatry, 55, 500
  2. Goodman WK, 1999, J Clin Psychiatry, 60, 27
  3. 10.1345/aph.1A102 · doi:10.1345/aph.1a102 · Paper page
  4. McMeekin H, 2003, J S C Med Assoc, 98, 316
  5. March J, 1997, J Clin Psychiatry, 58, 1
  6. Spreen O, 1977, Neurosensory Center Comprehensive Examination For Aphasia (NCCEA)
  7. Trenerry MR, 1989, Stroop Neuropsychological Screening Test

Cited by

See all 103

Metadata

Authors
Bruno, A., Micò, U., Pandolfo, G., Mallamace, D., Abenavoli, E., Di Nardo, F., D’Arrigo, C., Spina, E., Zoccali, R. A., & Muscatello, M. R. A.
Affiliations
  • University of Messina (IT)
  • Section of Psychiatry, Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy
Venue
Journal of Psychopharmacology
Published
2012-02-20
Volume
26
Issue
11
Pages
1456-1462
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2120585702
Cited by
103
References
56
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 5 · 2015: 11 · 2014: 15 · 2013: 6
FWCI
11.60
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
lamotrigine, treatment-resistant OCD, serotonin reuptake inhibitors, drug augmentation, obsessions and compulsions, depressive symptoms, cognitive function, semantic fluency, tolerability
MeSH terms
Lamotrigine, Adult, Aged, Anticonvulsants, Cognition, Double-Blind Method, Drug Resistance, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Triazines, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study. https://app.cochat.ai/papers/10.1177/0269881111431751
The paper
Bruno, A., Micò, U., Pandolfo, G., Mallamace, D., Abenavoli, E., Di Nardo, F., D’Arrigo, C., Spina, E., Zoccali, R. A., & Muscatello, M. R. A. (2012). Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881111431751

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.